Sankyo launches angiontensin II antagonist/diuretic combination

Sankyo Pharma has launched Olmetec Plus, a fixed dose combination of the angiotensin II antagonist olmesartan, and the thiazide diuretic hydrochlorothiazide, for the treatment of hypertension in patients whose blood pressure is not adequately controlled by olmesartan alone.

Olmetec Plus is available in two strengths - 20 mg/12.5 mg and 20mg/25 mg - each containing 20mg olmesartan medoxomil and either 12.5 mg or 25 mg hydrochlorothiazide.

Olmetec Plus is not indicated for use in initial therapy of hypertension. Patients inadequately controlled by olmesartan alone should be started on Olmetec Plus 20mg/12.5 mg once daily, increasing to Olmetec Plus 20mg/25mg if blood pressure is still not adequately controlled.

Both strengths of Olmetec Plus are presented in packs of 28 tablets and have the same basic NHS price of £12.95.

Further information: Sankyo Pharma UK Ltd, Repton Place, White Lion Road, Amersham, Bucks, HP7 9LP. Tel: (01494) 766866.
Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more